Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 5

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Anorexia–cachexia syndrome-like hypothalamic neuroendocrine dysfunction in a patient with a papillary craniopharyngioma

Balcázar-Hernández, Lourdes, Vargas-Ortega, Guadalupe, Valverde-García, Yelitza, Mendoza-Zubieta, Victoria, González-Virla, Baldomero·2017·Endocrinology, Diabetes & Metabolism Case Reports
DOI 10.1530/edm-17-0018
Open this paper in CoChat — free account

Abstract

Summary: The craniopharyngiomas are solid cystic suprasellar tumors that can present extension to adjacent structures, conditioning pituitary and hypothalamic dysfunction. Within hypothalamic neuroendocrine dysfunction, we can find obesity, behavioral changes, disturbed circadian rhythm and sleep irregularities, imbalances in the regulation of body temperature, thirst, heart rate and/or blood pressure and alterations in dietary intake (like anorexia). We present a rare case of anorexia–cachexia syndrome like a manifestation of neuroendocrine dysfunction in a patient with a papillary craniopharyngioma. Anorexia–cachexia syndrome is a complex metabolic process associated with underlying illness and characterized by loss of muscle with or without loss of fat mass and can occur in a number of diseases like cancer neoplasm, non-cancer neoplasm, chronic disease or immunodeficiency states like HIV/AIDS. The role of cytokines and anorexigenic and orexigenic peptides are important in the etiology. The anorexia–cachexia syndrome is a clinical entity rarely described in the literature and it leads to important function limitation, comorbidities and worsening prognosis. Learning points: Suprasellar lesions can result in pituitary and hypothalamic dysfunction. The hypothalamic neuroendocrine dysfunction is commonly related with obesity, behavioral changes, disturbed circadian rhythm and sleep irregularities, but rarely with anorexia–cachexia. Anorexia–cachexia syndrome is a metabolic process associated with loss of muscle, with or without loss of fat mass, in a patient with neoplasm, chronic disease or immunodeficiency states. Anorexia–cachexia syndrome results in important function limitation, comorbidities that influence negatively on treatment, progressive clinical deterioration and bad prognosis that can lead the patient to death. Anorexia–cachexia syndrome should be suspected in patients with emaciation and hypothalamic lesions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/edm-17-0018

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 40

  1. Stamm, 2011, Craniopharyngioma, Otolaryngologic Clinics of North America, 44, 937, 10.1016/j.otc.2011.06.015 · DOI
  2. Müller, 2014, Craniopharyngioma, Handbook of Clinical Neurology, 124, 235, 10.1016/B978-0-444-59602-4.00016-2 · DOI
  3. Fahlbusch, 1999, Surgical treatment of craniopharyngiomas: experience with 168 patients, Journal of Neurosurgery, 90, 237, 10.3171/jns.1999.90.2.0237 · DOI · Paper page
  4. Bunin, 1998, The descriptive epidemiology of craniopharyngioma, Journal of Neurosurgery, 89, 547, 10.3171/jns.1998.89.4.0547 · DOI · Paper page
  5. Parisi, 1993, Nonglial tumours, Principles and Practice of Neuropathology, 203
  6. Weiner, 1994, Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome, Neurosurgery, 35, 1001, 10.1227/00006123-199412000-00001 · DOI · Paper page
  7. Lena, 2005, Craniopharyngioma in children: Marseille experience, Child’s Nervous System, 21, 778e784
  8. Shi, 2008, Craniopharyngioma: surgical experience of 309 cases in China, Clinical Neurology and Neurosurgery, 110, 151, 10.1016/j.clineuro.2007.10.013 · DOI
  9. Lopez-Serna, 2012, Reply: classification systems of adult craniopharyngiomas: the need for an accurate definition of the hypothalamus-tumor relationships, Archives of Medical Research, 43, 591, 10.1016/j.arcmed.2012.10.005 · doi:10.1016/j.arcmed.2012.10.005
  10. Daubenbüchel, 2015, Neuroendocrine disorders in pediatric craniopharyngioma patients, Journal of clinical medicine, 4, 389, 10.3390/jcm4030389 · DOI
  11. Elliott, 2010, Surgical management of giant pediatric craniopharyngiomas, Journal of Neurosurgery-Pediatrics, 6, 403, 10.3171/2010.8.PEDS09385 · DOI
  12. Poretti, 2004, Outcome of craniopharyngioma in children: long-term complications and quality of life, Developmental Medicine and Child Neurology, 46, 220, 10.1111/j.1469-8749.2004.tb00476.x · DOI · Paper page
  13. Russell, 1951, A diencephalic syndrome of emaciation in infancy and childhood, Archives of Disease in Childhood, 26, 274
  14. Hoffmann, 2014, Diencephalic syndrome in childhood craniopharyngioma-results of German multicenter studies on 485 long-term survivors of childhood craniopharyngioma, Journal of Clinical Endocrinology and Metabolism, 99, 3972, 10.1210/jc.2014-1680 · DOI · Paper page
  15. MacDonald, 2003, Understanding and managing cancer cachexia, Journal of the American College of Surgeons, 197, 143, 10.1016/S1072-7515(03)00382-X · DOI · Paper page
  16. Mazzotta, 2009, Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated Fatty acids in the management of symptoms, survival, and quality of life, Journal of Pain and Symptom Management, 37, 1069, 10.1016/j.jpainsymman.2008.06.005 · DOI
  17. Evans, 2008, Cachexia: a new definition, Clinical Nutrition, 27, 793, 10.1016/j.clnu.2008.06.013 · DOI · Paper page
  18. MacDonald, 2003, Understanding and managing cancer cachexia, Journal of the American College of Surgeons, 197, 143, 10.1016/S1072-7515(03)00382-X · DOI · Paper page
  19. Mazzotta, 2009, Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated Fatty acids in the management of symptoms, survival, and quality of life, Journal of pain and symptom management, 37, 1069, 10.1016/j.jpainsymman.2008.06.005 · DOI
  20. Plata-Salaman, 1996, Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations, Physiology and Behavior, 60, 86, 10.1016/0031-9384(96)00148-5 · DOI
  21. Chesnokova, 2000, Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation, Endocrinology, 141, 4032, 10.1210/endo.141.11.7778 · DOI
  22. Bendtzen, 1984, Demonstration of circulating leukocytic pyrogen/interleukin-1 during fever, New England Journal of Medicine, 310, 596, 10.1056/NEJM198403013100915 · doi:10.1056/nejm198403013100915
  23. Krueger, 1998, A physiologic role for IL-1 beta and TNF-alpha, Annals of New York Academy of Sciences, 856, 148, 10.1111/j.1749-6632.1998.tb08323.x · DOI · Paper page
  24. Irwin, 2007, Depressive disorders and immunity: 20 years of progress and discovery, Brain, Behavior, and Immunity, 21, 374, 10.1016/j.bbi.2007.01.010 · DOI · Paper page
  25. Sonti, 1996, Anorexia induced by cytokine interactions at pathophysiological concentrations, American Physiological Society, 270, R1394
  26. Plata-Salaman, 1996, Anorexia induced by activators of the signal transducer gp130, Neuroreport, 7, 841, 10.1097/00001756-199602290-00038 · DOI
  27. Hasselgren, 2002, Molecular regulation of muscle cachexia: it may be more than the proteasome, Biochemical and Biophysical Research Communications, 290, 1, 10.1006/bbrc.2001.5849 · DOI · Paper page
  28. Grossberg, 2010, Hypothalamic mechanisms in cachexia, Physiology and Behavior, 100, 478, 10.1016/j.physbeh.2010.03.011 · DOI · Paper page
  29. Banks, 2001, Anorectic effects of circulating cytokines: role of the vascular blood-brain barrier, Nutrition, 17, 434, 10.1016/S0899-9007(01)00507-X · DOI
  30. Plata-Salaman, 1998, Cytokines and anorexia: a brief overview, Seminars in Oncology, 25, 64
  31. Turrin, 2000, Cytokine–cytokine interactions and the brain, Brain Research Bulletin, 51, 3, 10.1016/S0361-9230(99)00203-8 · DOI
  32. Grossberg, 2010, Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130, Endocrinology, 151, 606, 10.1210/en.2009-1135 · DOI
  33. Garfield, 2009, Role of central melanocortin pathways in energy homeostasis, Trends in Endocrinology and Metabolism, 20, 203, 10.1016/j.tem.2009.02.002 · DOI
  34. Cheung, 2005, Role of leptin and melanocortin signaling in uremia-associated cachexia, Journal of Clinical Investigation, 115, 1659, 10.1172/JCI22521 · DOI · Paper page
  35. Marks, 2003, Differential role of melanocortin receptor subtypes in cachexia, Endocrinology, 144, 1513, 10.1210/en.2002-221099 · DOI
  36. Minokoshi, 2004, AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus, Nature, 428, 569, 10.1038/nature02440 · DOI · Paper page
  37. Kievit, 2006, Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells, Cell Metabolism, 4, 123, 10.1016/j.cmet.2006.06.010 · DOI · Paper page
  38. Anisman, 1999, Anhedonic and anxiogenic effects of cytokine exposure, Advances in Experimental Medicine and Biology, 461, 199, 10.1007/978-0-585-37970-8_12 · DOI · Paper page
  39. Mesaros, 2008, Activation of Stat3 signaling in AgRP neurons promotes locomotor activity, Cell Metabolism, 7, 236, 10.1016/j.cmet.2008.01.007 · DOI · Paper page
  40. Cone, 2005, Anatomy and regulation of the central melanocortin system, Nature Neuroscience, 8, 571, 10.1038/nn1455 · DOI · Paper page

Cited by

See all 5

Metadata

Authors
Balcázar-Hernández, L., Vargas-Ortega, G., Valverde-García, Y., Mendoza-Zubieta, V., & González-Virla, B.
Affiliations
  • 1Endocrinology Department
  • 2Anatomic Pathology Department, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Colonia Doctores, Mexico City Mexico
Venue
Endocrinology, Diabetes & Metabolism Case Reports
Publisher
Bioscientifica
Published
2017-04-21
Volume
2017
ISSN
2052-0573
DOI
10.1530/edm-17-0018
Cited by
5
References
4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anorexia–cachexia syndrome-like hypothalamic neuroendocrine dysfunction in a patient with a papillary craniopharyngioma. https://app.cochat.ai/papers/10.1530/edm-17-0018
The paper
Balcázar-Hernández, L., Vargas-Ortega, G., Valverde-García, Y., Mendoza-Zubieta, V., & González-Virla, B. (2017). Anorexia–cachexia syndrome-like hypothalamic neuroendocrine dysfunction in a patient with a papillary craniopharyngioma. Endocrinology, Diabetes & Metabolism Case Reports. https://doi.org/10.1530/edm-17-0018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.